Total Payments
$10,957
2024 Payments
$10,845
Companies
5
Transactions
12
Medicare Patients
1,151
Medicare Billing
$98,331
Payment Breakdown by Category
Consulting$9,394 (85.7%)
Travel$1,377 (12.6%)
Food & Beverage$186.05 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,394 | 1 | 85.7% |
| Travel and Lodging | $1,377 | 2 | 12.6% |
| Food and Beverage | $186.05 | 9 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $10,821 | 4 | $0 (2024) |
| Incyte Corporation | $77.04 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $32.07 | 2 | $0 (2018) |
| Mannkind Corporation | $16.16 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $10.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,845 | 5 | GENZYME CORPORATION ($10,821) |
| 2023 | $22.46 | 1 | Incyte Corporation ($22.46) |
| 2022 | $14.09 | 1 | Incyte Corporation ($14.09) |
| 2021 | $16.54 | 1 | Incyte Corporation ($16.54) |
| 2018 | $18.58 | 1 | SANOFI-AVENTIS U.S. LLC ($18.58) |
| 2017 | $40.44 | 3 | Mannkind Corporation ($16.16) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: Dermatology | ||||||
| 04/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $9,394.00 | General |
| Category: Immunology | ||||||
| 04/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,072.70 | General |
| Category: Immunology | ||||||
| 04/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Immunology | ||||||
| 04/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Immunology | ||||||
| 08/29/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Dermatology | ||||||
| 02/08/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Dermatology | ||||||
| 10/28/2021 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Dermatology | ||||||
| 01/08/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: DIABETES | ||||||
| 11/06/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: DIABETES | ||||||
| 08/25/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Respiratory | ||||||
| 04/06/2017 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 325 | 1,540 | $60,770 | $27,033 |
| 2022 | 8 | 282 | 1,568 | $55,153 | $25,964 |
| 2021 | 8 | 285 | 1,664 | $54,388 | $26,992 |
| 2020 | 8 | 259 | 888 | $41,664 | $18,341 |
Total Patients
1,151
Total Services
5,660
Medicare Billing
$98,331
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 155 | $20,150 | $9,720 | 48.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 12 | 380 | $8,360 | $4,218 | 50.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $5,440 | $2,878 | 52.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 76 | $6,080 | $2,847 | 46.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 20 | 220 | $5,622 | $1,872 | 33.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 18 | 592 | $5,328 | $1,773 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $3,240 | $1,578 | 48.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 45 | 50 | $4,750 | $1,375 | 29.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $1,800 | $771.68 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 130 | $16,900 | $8,371 | 49.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 15 | 380 | $8,360 | $4,469 | 53.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 84 | $6,720 | $3,162 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 31 | $5,580 | $3,082 | 55.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $4,010 | $2,170 | 54.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 16 | 671 | $6,039 | $2,066 | 34.2% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 20 | 232 | $5,874 | $1,869 | 31.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $1,670 | $775.67 | 46.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 88 | 122 | $14,570 | $8,134 | 55.8% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 15 | 390 | $8,580 | $4,585 | 53.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 39 | 39 | $5,850 | $3,298 | 56.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 69 | 76 | $5,580 | $3,168 | 56.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 32 | $5,760 | $3,109 | 54.0% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 16 | 754 | $6,786 | $2,090 | 30.8% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 21 | 239 | $5,942 | $1,923 | 32.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 12 | 12 | $1,320 | $686.16 | 52.0% |
About Michael Sheehan
Michael Sheehan is a Allergy & Immunology healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194717108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Sheehan has received a total of $10,957 in payments from pharmaceutical and medical device companies, with $10,845 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($9,394).
As a Medicare-enrolled provider, Sheehan has provided services to 1,151 Medicare beneficiaries, totaling 5,660 services with total Medicare billing of $98,331. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Syracuse, NY
- Active Since 08/16/2005
- Last Updated 03/21/2017
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1194717108
Products in Payments
- DUPIXENT (Biological) $10,821
- OPZELURA (Drug) $77.04
- TOUJEO (Drug) $32.07
- AFREZZA (Drug) $16.16
- BEVESPI AEROSPHERE (Drug) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.